About Shanghai Kehua Bio-engineering Company

The company was founded in 1981 and listed on the small and medium board of the Shenzhen Stock Exchange in 2004 (stock code: 002022.SZ). It is an in vitro diagnostic company integrating R&D, production and sales, with rich production experience and a complete hierarchy of medical diagnostic products. Headquartered in Shanghai, it has R&D and production bases in Italy, Shenzhen, Xi'an, Suzhou and other countries and regions, and currently has nearly 2,000 employees. The company's main business is R&D, production and sales of in vitro diagnostic reagents and medical testing instruments. Reagent products cover infectious diseases, cardiovascular health, liver disease, kidney disease, tumors, reproductive health, maternal and child health, genetic disease testing, pharmacogenomics, animal disease testing, etc. The instrument products achieve full coverage in the fields of biochemical diagnosis, immune diagnosis, molecular diagnosis, and immediate diagnosis (POCT). Corporate honors: High-tech Enterprise, 2022 Shanghai Top 100 Manufacturing Enterprises, China's Top 100 SME Innovators, Shanghai Famous Brand, “Shanghai Famous Brand”, “Shanghai Science and Technology Award (Magnetic Nano Microsphere Controllable Preparation Technology and Molecular Diagnosis Kit)”, “Shanghai Innovative Enterprise”, etc.